Asunto(s)
Síndromes Periódicos Asociados a Criopirina/complicaciones , Síndromes Periódicos Asociados a Criopirina/tratamiento farmacológico , Endometriosis/complicaciones , Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico , Interleucina-1beta/antagonistas & inhibidores , Endometriosis/diagnóstico por imagen , Femenino , Humanos , Interleucina-1beta/análisis , Persona de Mediana Edad , Mutación , Proteína con Dominio Pirina 3 de la Familia NLR/genéticaRESUMEN
Ipragliflozin is a new drug for the treatment of diabetes mellitus. Its action of sodium-glucose cotransporter 2 (SGLT2) inhibition induces glucosuria and decreases blood glucose levels. We report the first case of ipragliflozin-related eczematous drug eruption and a review of the past literature on drug eruptions caused by SGLT2 inhibitors.
Asunto(s)
Erupciones por Medicamentos/etiología , Glucósidos/efectos adversos , Hipoglucemiantes/efectos adversos , Tiofenos/efectos adversos , Anciano , Diabetes Mellitus/tratamiento farmacológico , Erupciones por Medicamentos/patología , Humanos , MasculinoRESUMEN
We report on the first case of pyogenic granulomas caused by afatinib. We also review the current literature concerning pyogenic granulomas caused by epidermal growth factor receptor tyrosine kinase inhibitors.
Asunto(s)
Antineoplásicos/efectos adversos , Granuloma Piogénico/inducido químicamente , Dermatosis de la Mano/inducido químicamente , Quinazolinas/efectos adversos , Afatinib , Anciano , Femenino , Dedos , HumanosAsunto(s)
Antibacterianos/efectos adversos , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/metabolismo , Interleucina-23/análisis , Ácido Penicilánico/análogos & derivados , Erupciones por Medicamentos/patología , Humanos , Interleucina-17/análisis , Interleucina-23/biosíntesis , Masculino , Persona de Mediana Edad , Paraqueratosis/inducido químicamente , Paraqueratosis/patología , Ácido Penicilánico/efectos adversos , Piperacilina/efectos adversos , Combinación Piperacilina y TazobactamRESUMEN
BACKGROUND: An anaphylactoid purpura affects small capillaries in the skin and other organs. Although two cases of anaphylactoid purpura exacerbated by cellulitis have been reported in Japanese literatures, its prognosis remains still unclear. Because cellulitis exacerbates various cutaneous inflammations, it has been speculated that cellulitis might also exacerbate cutaneous inflammation, such as vasculitis. FINDINGS: In this article, we report that 78-year-old woman exhibited anaphylactoid purpura, following cellulitis. We also reviewed the literature concerning about this subject. CONCLUSIONS: This type of anaphylactoid purpura is thought to have a favorable prognosis dependent on the treatment for cellulitis.
Asunto(s)
Artritis Reumatoide/inmunología , Interleucina-17/inmunología , Interleucina-23/inmunología , Nódulo Reumatoide/inmunología , Artritis Reumatoide/complicaciones , Artritis Reumatoide/metabolismo , Humanos , Inmunohistoquímica , Interleucina-17/metabolismo , Interleucina-23/metabolismo , Linfocitos/inmunología , Linfocitos/metabolismo , Nódulo Reumatoide/complicaciones , Nódulo Reumatoide/metabolismo , Transducción de Señal/inmunología , Piel/inmunología , Piel/metabolismo , Piel/patologíaAsunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Antirreumáticos/efectos adversos , Erupciones por Medicamentos/etiología , Eritema Multiforme/inducido químicamente , Trastornos por Fotosensibilidad/inducido químicamente , Artritis Reumatoide/tratamiento farmacológico , Femenino , Humanos , Persona de Mediana EdadRESUMEN
BACKGROUND: It is important to predict walking ability for stroke patients, because rehabilitation programs are planned on such predictions. We therefore examined predictive factors that are available before discharge from a rehabilitation hospital. METHODS: Seventy-two consecutive patients with a first attack of stroke with severe hemiplegia were included in this study. We retrospectively evaluated background factors (age, gender, time from stroke onset, paresis side, and stroke type). Other neurological and physical parameters were collected by means of the modified National Institutes of Health Stroke Scale, the Mini-Mental State Examination, the Trunk Control Test (TCT), and the knee extension strength/body weight ratio on the unaffected side (KES/BW-US) at the time of admission. We divided the patients into 2 groups, the independent group (n = 49) and the dependent group (n = 23), on the basis of the Barthel Index of mobility at the time of discharge. We then compared the 2 groups with respect to the aforementioned parameters. We also performed stepwise discriminant analyses to ascertain which parameters are the best predictors of walking ability at the time of discharge. RESULTS: Age, TCT score, and the KES/BW-US ratio were significantly different between the groups. Discriminant analysis revealed that younger age and a higher KES/BW-US ratio were significantly associated with walking ability at discharge, which could be precisely predicted using the following formula: Y = .093 × (age) - 4.316 × (KES/BW-US) - 4.984. CONCLUSIONS: At the time of admission, age and the KES/BW-US ratio permit the prediction of independent walking ability at the time of discharge. Our formula predicts walking ability with an accuracy of more than 91%.